BioSpace News Archive

Exopharm Limited has been granted US patent US 11202805 for its LEAP™ exosome purification technology.

iXensor Confirms PixoTest ® COVID-19 Antigen Test Detects Omicron and Other Key Variants of Concern.

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the United Kingdom Government will purchase an additional 1.75 million patient courses of molnupiravir, an investigational oral antiviral COVID-19 medicine.

Protalix BioTherapeutics, Inc. today announced the following letter from its President and Chief Executive Officer, Dror Bashan, to its stockholders and the investment community.

The company adds BD Veritor™ At-Home COVID-19 Test to its fully-integrated COVID-19 digital platform combining testing, telehealth, and treatment.

Agios Pharmaceuticals, Inc. today announced that the company is scheduled to present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 7:30 a.m. ET.

The University of Alabama at Birmingham (UAB) and Mereo BioPharma Group plc today announced top-line data from a Phase 1b/2 clinical trial evaluating alvelestat, a novel, orally active Neutrophil Elastase (NE) inhibitor in hospitalized COVID-19 Respiratory Disease patients.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical company, today announced the BD Veritor™ At-Home COVID-19 Test is now available for purchase through Everly Health.

Beta Bionics, Inc. today announced the completion of the randomized controlled trial for the Insulin-Only Bionic Pancreas Pivotal Trial and enrollment into the screening protocol of the Bihormonal Bionic Pancreas Pivotal Trial at Massachusetts General Hospital.

Bausch Health Companies Inc. today announced that The Journal of Emergency Medicine has published a new post-hoc analysis of pooled results on the safety and efficacy of a single dose of RELISTOR® (methylnaltrexone bromide) injection in patients with severe illness and opioid-induced constipation (OIC) who had insufficient response to laxative therapy.